Buy or sell Flatiron Health stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Flatiron Health Stock
Cloud Based Tech Improving Cancer Care
About Flatiron Health Stock
Flatiron Health is a healthcare IT company based in New York City. Flatiron's mission to improve cancer care by organizing the world's real-world oncology data. We'll do this by connecting and standardizing cancer centers around the world on a common technology platform. This will allow researchers, physicians and patients to learn from the millions of patients already being treated every year. From there, our goal is to accelerate research, optimize treatment by enabling personalized medicine, and help physicians and patients make better data-driven decisions. Flatiron Health was started in 2012 by two of the founders of Invite Media, an advertising technology company acquired by Google in 2010.
Investors
Allen & Company
Stripe, Vroom, Ginkgo Bioworks, Joby Aviation, Convoy, Turo, Blend, OfferUp, Vox Media, Minted
Baillie Gifford
Spotify, Indigo, Ginkgo Bioworks, Joby Aviation, AUTO1 Group, Carbon, Tempus, HeartFlow, Graphcore, Thumbtack
BoxGroup
Scopely, Dataminr, Zipline, Blue Apron, Plaid, Matterport, Guideline, Flatiron Health, PillPack, MIRROR
First Round Capital
Flexport, AppNexus, Blue Apron, LendingHome, Clover Health, Fab, Roblox, Earnest, Warby Parker, Boxed
Great Oaks Venture Capital
Collective Health, Acorns, Hired, SingleStore, Shift, Pocket Gems, Course Hero, Happy Money, Flatiron Health, Petal
Social Capital
Slack, Netskope, Box, Clover Health, Intercom, CommonBond, Wealthfront, Flatiron Health, mParticle, Greenhouse Software
Funding History
May 2014 | $130M |
---|
Management
Co-Founder
Nat Turner
Co-Founder
Zach Weinberg
Press
Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Flatiron Health or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.